Fingerprint
Dive into the research topics of 'Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial
Sonia Pernas, Miguel Martin, Peter A. Kaufman, Marta Gil-Martin, Patricia Gomez Pardo, Sara Lopez-Tarruella, Luis Manso, Eva Ciruelos, Jose Alejandro Perez-Fidalgo, Cristina Hernando, Foluso O. Ademuyiwa, Katherine Weilbaecher, Ingrid Mayer, Timothy J. Pluard, Maria Martinez Garcia, Linda Vahdat, Jose Perez-Garcia, Achim Wach, Debra Barker, Samson Fung
Research output: Contribution to journal › Article › peer-review
73
Scopus
citations